Trending...
- Mortgage Rates And Demand Are Stuck In A Holding Pattern
- Google AI Quietly Corrects the Record on Republic of Aquitaine's Legal Sovereignty
- Joyce Carol Oates Returns to Hard Case Crime With DOUBLE TROUBLE
To become the premier provider of internationally sourced, affordable prescription medications for health plans and individuals, Care2Care International is now offering an equity crowdfunding opportunity through TycoonInvest.
PORTSMOUTH, N.H. - WisconsinEagle -- Care2Care International (C2C) is striving to provide value to healthcare plans and individual patients, and its growth potential is significant. This is why we asked our partner TycoonInvest to help us raise $400,000 to create jobs, expand our marketing reach, further develop our patient platform, and invest in sourcing partnerships.
C2C provides international pharmacy mail-order services, and is striving to help patients in the United States fully and easily exercise their right to import prescription drugs for personal use, individually or through their health plan.
To this end, C2C provides a simple solution for procuring US FDA-approved medications delivering huge savings for hundreds of costly prescription drugs.
During the last decade, drug prices have increased by 84%, outpacing any other medical commodity or service. While brand and specialty drug prices are now 3 to 5 times higher than in other developed countries, this gap continues to grow rapidly! Despite many formal announcements in the last years, no real reform has been put in place and none is realistically in sight.
More on Wisconsin Eagle
Meanwhile, every year, over 4 million Americans buy their drugs for personal use abroad. Their rights of importing medications for personal use are protected by Congress, which reiterated its will as recently as 2018, as part of the Opioid Bill.
Contracting with brick-and-mortar pharmacies in Canada and European countries, Care2Care provides easy access via a patient portal. The pharmacies deliver the medications through mail-order, a solution many Americans are now accustomed to.
C2C's interests are completely aligned with their clients' as shown by the moderate, win-win performance fee which is a function of the actual savings generated: the more the client saves, the more C2C gets paid.
Care2Care target market is the employer self-funded health plans, whose drug spending represents now roughly 25% of their total costs and is the fastest-growing item. These plans are therefore in dire need of real cost containment solutions.
C2C markets its services directly to employers directly or partnering with consultants, brokers, or providers sharing the same values: deliver a fair and high-value service to American people in search of real solutions for their health needs, at an affordable and transparent cost.
More on Wisconsin Eagle
Care2Care is proud to announce a strategic partnership with an innovative, transparent, 100% pass-through PBM, expanding C2C's offer and expertise to the full pharmacy benefit management. This new service called Care2Care Choice Rx™ will allow C2C to reach out to employers with a comprehensive pharmacy solution to achieve the lowest net cost reference price. At stake: for the employer, a potential cost reduction of 40%+ of Rx expenditures, meaning 10%+ of total health care plan spending; for Care2Care, another revenue stream from a broader range of clients.
Making it safe and easy, Care2care International ambitions to become the premier provider of internationally sourced affordable prescription medications for health plans and individuals while promoting a comprehensive cost-effective pharmacy solution for everyone.
For more information about our Reg CF Offering, visit the investment platform at https://tycooninvest.com/care2care.
C2C provides international pharmacy mail-order services, and is striving to help patients in the United States fully and easily exercise their right to import prescription drugs for personal use, individually or through their health plan.
To this end, C2C provides a simple solution for procuring US FDA-approved medications delivering huge savings for hundreds of costly prescription drugs.
During the last decade, drug prices have increased by 84%, outpacing any other medical commodity or service. While brand and specialty drug prices are now 3 to 5 times higher than in other developed countries, this gap continues to grow rapidly! Despite many formal announcements in the last years, no real reform has been put in place and none is realistically in sight.
More on Wisconsin Eagle
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
Meanwhile, every year, over 4 million Americans buy their drugs for personal use abroad. Their rights of importing medications for personal use are protected by Congress, which reiterated its will as recently as 2018, as part of the Opioid Bill.
Contracting with brick-and-mortar pharmacies in Canada and European countries, Care2Care provides easy access via a patient portal. The pharmacies deliver the medications through mail-order, a solution many Americans are now accustomed to.
C2C's interests are completely aligned with their clients' as shown by the moderate, win-win performance fee which is a function of the actual savings generated: the more the client saves, the more C2C gets paid.
Care2Care target market is the employer self-funded health plans, whose drug spending represents now roughly 25% of their total costs and is the fastest-growing item. These plans are therefore in dire need of real cost containment solutions.
C2C markets its services directly to employers directly or partnering with consultants, brokers, or providers sharing the same values: deliver a fair and high-value service to American people in search of real solutions for their health needs, at an affordable and transparent cost.
More on Wisconsin Eagle
- Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- Colbert Packaging Receives Safe Quality Food (SQF) Certification
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
Care2Care is proud to announce a strategic partnership with an innovative, transparent, 100% pass-through PBM, expanding C2C's offer and expertise to the full pharmacy benefit management. This new service called Care2Care Choice Rx™ will allow C2C to reach out to employers with a comprehensive pharmacy solution to achieve the lowest net cost reference price. At stake: for the employer, a potential cost reduction of 40%+ of Rx expenditures, meaning 10%+ of total health care plan spending; for Care2Care, another revenue stream from a broader range of clients.
Making it safe and easy, Care2care International ambitions to become the premier provider of internationally sourced affordable prescription medications for health plans and individuals while promoting a comprehensive cost-effective pharmacy solution for everyone.
For more information about our Reg CF Offering, visit the investment platform at https://tycooninvest.com/care2care.
Contact
Pascal Orliac
Co-founder and Chief Marketing Officer
www.care2careinternational.com
pascal@care2caremedicaltravel.com
+1 603 781-4947
Pascal Orliac
Co-founder and Chief Marketing Officer
www.care2careinternational.com
pascal@care2caremedicaltravel.com
+1 603 781-4947
Source: Care2Care International
Filed Under: Business
0 Comments
Latest on Wisconsin Eagle
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- Colorado Scenthound Locations Partner with Humane Colorado to Give Adopted Dogs a "Clean Start"
- Endoacustica Europe Unveils iPhone 13 Pro Max Spy Phone—Pure Hardware, Zero Software Changes
- Suzanne Harp named Managing Director in Texas, USA
- Association for Diagnostics & Laboratory Medicine (formerly AACC) elects new leaders to serve terms starting in August 2025
- $10 Million Acquisition of GXR World Sports Assets Energizes Global Launch of Sports.com Super App by Online Lottery-Sports Game Provider: Lottery.com
- Shop American Made Goods: New Online Marketplace My American Goods Curates the Best of U.S. Made
- Investor Spotlight: Cycurion, Inc. (N A S D A Q: CYCU) Secures $69M in Contracts Amid Surging Demand for AI-Powered Cybersecurity Solutions
- $328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
- Ascent Solar Technologies Enters Collaborative Agreement Notice with NASA to Advance Development of Thin-Film PV Power Beaming Capabilities: ASTI
- VoodooSoft Unveils SiriusLLM: The World's First ChatGPT-Like AI Malware Detection Engine
- This Ain't Press. This Is Pressure — Star Command by RansomXX is Out Now
- An Exclusive VIP Reception Honoring Vocal Prodigy Alliana Lili Yang's Remarkable Achievements and Magazine Cover Spotlight
- Joyce Carol Oates Returns to Hard Case Crime With DOUBLE TROUBLE
- New AI Academy Helps Therapists Embrace Tech Without Losing Their Humanity
- Robinson provides commercial manufacturing and assembly in the USA
- Rosalind Franklin University Helix 51 Company UP Oncolytics Secures Wisconsin Economic Development Matching Grant to Advance Oncolytic Virus Therapy for Brain Cancer
- IQSTEL Surges Toward $400M Run Rate with $101.5M in Revenue—Reinforces Billion-Dollar Vision Backed by Fintech, AI, and Cybersecurity
- Alpha Modus Files 7th IP Action Against Rackspace Following $3M CEO Investment and Strategic Partnership Expansion
- Mortgage Rates And Demand Are Stuck In A Holding Pattern